Header Logo

Annabelle Santos Volgman

Concepts (370)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
24
2023
110
7.980
Why?
Cardiovascular Diseases
22
2024
338
5.680
Why?
Stroke
21
2023
255
4.480
Why?
Heart Failure
8
2023
148
2.660
Why?
Female
79
2024
14520
2.160
Why?
Humans
104
2024
26260
2.060
Why?
Transcatheter Aortic Valve Replacement
4
2023
14
2.010
Why?
Aortic Valve Stenosis
4
2023
17
2.010
Why?
Anticoagulants
7
2022
84
1.950
Why?
Myocardial Infarction
11
2023
122
1.860
Why?
Coronary Artery Disease
8
2022
98
1.790
Why?
Risk Factors
32
2024
2221
1.770
Why?
Healthcare Disparities
6
2020
84
1.700
Why?
Sex Factors
18
2022
456
1.630
Why?
Pregnancy Complications, Cardiovascular
6
2023
15
1.560
Why?
Hospital Mortality
8
2023
130
1.530
Why?
Cardiologists
2
2023
7
1.520
Why?
Exercise
7
2022
416
1.450
Why?
Cardiology
5
2022
42
1.410
Why?
Cognitive Dysfunction
6
2024
989
1.400
Why?
Risk Assessment
14
2022
592
1.370
Why?
Sex Characteristics
7
2023
109
1.290
Why?
Hospitalization
8
2021
290
1.280
Why?
Myocardial Ischemia
4
2022
27
1.270
Why?
Women's Health
4
2020
151
1.270
Why?
Life Style
8
2020
185
1.240
Why?
Aged
41
2024
8595
1.220
Why?
Male
48
2023
14168
1.210
Why?
Primary Prevention
4
2022
35
1.160
Why?
Quality of Life
8
2023
606
1.160
Why?
Acute Kidney Injury
3
2023
44
1.150
Why?
Cardiovascular System
3
2022
12
1.150
Why?
United States
27
2023
2043
1.130
Why?
Physicians, Women
3
2022
14
1.100
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2020
60
1.080
Why?
Pacemaker, Artificial
3
2023
18
1.050
Why?
Catheter Ablation
3
2022
61
1.020
Why?
Arrhythmias, Cardiac
6
2019
68
1.020
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2020
24
0.960
Why?
Adrenergic beta-Antagonists
2
2020
27
0.960
Why?
Middle Aged
33
2024
8541
0.960
Why?
Defibrillators, Implantable
3
2021
11
0.940
Why?
Health Status Disparities
4
2019
68
0.940
Why?
Anti-Arrhythmia Agents
7
2022
33
0.920
Why?
American Heart Association
4
2023
17
0.880
Why?
Ischemic Attack, Transient
2
2023
17
0.860
Why?
Terminal Care
1
2023
26
0.820
Why?
Echocardiography, Doppler, Color
2
2019
12
0.810
Why?
Heart Defects, Congenital
1
2023
29
0.800
Why?
Myocarditis
1
2022
11
0.790
Why?
Premature Birth
1
2022
9
0.790
Why?
Electrocardiography
7
2015
95
0.770
Why?
Pregnancy
9
2023
312
0.760
Why?
Breast Neoplasms
3
2021
391
0.740
Why?
Coronavirus
1
2021
1
0.740
Why?
Length of Stay
4
2020
290
0.730
Why?
Chest Pain
1
2020
16
0.690
Why?
Brain Ischemia
1
2021
59
0.690
Why?
Intersectoral Collaboration
1
2020
7
0.690
Why?
Endothelium
1
2020
8
0.680
Why?
Vascular Diseases
1
2020
41
0.670
Why?
Treatment Outcome
14
2023
3285
0.670
Why?
Social Media
1
2021
47
0.660
Why?
Patient Care Management
2
2021
16
0.660
Why?
Takotsubo Cardiomyopathy
1
2019
10
0.660
Why?
Ambulatory Care Facilities
2
2022
34
0.650
Why?
Cognition
4
2024
1276
0.650
Why?
Cardiomyopathies
1
2019
25
0.650
Why?
Myxoma
1
2019
4
0.640
Why?
Heart Neoplasms
1
2019
9
0.640
Why?
Comorbidity
5
2021
468
0.640
Why?
Heart Diseases
1
2020
62
0.640
Why?
Betacoronavirus
1
2020
70
0.630
Why?
Age Factors
8
2021
744
0.630
Why?
Hypertension
7
2023
230
0.630
Why?
Heart Failure, Diastolic
1
2018
2
0.620
Why?
Heart Ventricles
1
2019
90
0.620
Why?
Prevalence
6
2020
441
0.620
Why?
Women's Health Services
1
2018
9
0.620
Why?
Coronavirus Infections
1
2020
80
0.610
Why?
Pneumonia, Viral
1
2020
84
0.600
Why?
Culturally Competent Care
1
2018
11
0.600
Why?
Delivery of Health Care, Integrated
1
2018
23
0.600
Why?
Warfarin
3
2016
25
0.600
Why?
Emigrants and Immigrants
1
2018
20
0.590
Why?
Antineoplastic Agents
1
2020
178
0.590
Why?
Atherosclerosis
1
2018
52
0.570
Why?
Prognosis
7
2021
710
0.540
Why?
Lipoprotein(a)
1
2016
4
0.520
Why?
Dyslipidemias
1
2016
16
0.510
Why?
Biomarkers
5
2024
556
0.510
Why?
Health Knowledge, Attitudes, Practice
2
2022
170
0.500
Why?
Diabetes Mellitus
3
2022
127
0.490
Why?
Electrodes
1
2015
10
0.490
Why?
Secondary Prevention
3
2022
52
0.480
Why?
Cost of Illness
1
2015
41
0.480
Why?
Social Support
1
2016
189
0.470
Why?
Adult
15
2023
7516
0.460
Why?
Magnetic Resonance Imaging
1
2019
1069
0.450
Why?
Aged, 80 and over
9
2021
4594
0.450
Why?
Electric Countershock
6
2020
10
0.440
Why?
Patient Readmission
3
2019
127
0.440
Why?
Aspirin
2
2020
82
0.440
Why?
Aortic Valve
3
2023
16
0.430
Why?
Retrospective Studies
10
2022
3283
0.420
Why?
Non-ST Elevated Myocardial Infarction
3
2022
4
0.410
Why?
ST Elevation Myocardial Infarction
3
2022
10
0.400
Why?
Atrial Appendage
2
2022
26
0.390
Why?
Cross-Sectional Studies
6
2024
875
0.380
Why?
Coronary Angiography
3
2020
71
0.380
Why?
Patient Acceptance of Health Care
1
2012
74
0.380
Why?
Alzheimer Disease
1
2023
2028
0.360
Why?
Frailty
2
2022
33
0.350
Why?
Cardiac Resynchronization Therapy Devices
2
2019
4
0.330
Why?
Cardiovascular Agents
2
2021
24
0.330
Why?
Hospital Costs
2
2020
60
0.330
Why?
Feasibility Studies
2
2020
199
0.330
Why?
Practice Guidelines as Topic
3
2021
294
0.310
Why?
Heart Atria
2
2019
25
0.290
Why?
Ventricular Fibrillation
2
2021
14
0.280
Why?
Percutaneous Coronary Intervention
3
2022
20
0.280
Why?
Cohort Studies
5
2023
1801
0.260
Why?
Health Status
2
2018
171
0.260
Why?
Administration, Oral
3
2016
105
0.250
Why?
Societies, Medical
3
2023
144
0.250
Why?
Randomized Controlled Trials as Topic
5
2020
303
0.250
Why?
Sex Distribution
3
2019
77
0.240
Why?
Palliative Care
2
2023
104
0.240
Why?
Antihypertensive Agents
2
2020
75
0.240
Why?
Hemorrhage
5
2020
76
0.230
Why?
Risk Adjustment
2
2021
10
0.230
Why?
Incidence
4
2020
709
0.230
Why?
Logistic Models
3
2021
353
0.230
Why?
Obesity
4
2020
299
0.220
Why?
Hospital Charges
2
2020
17
0.220
Why?
Young Adult
3
2020
1948
0.220
Why?
Illinois
2
2021
223
0.220
Why?
Leadership
2
2022
104
0.220
Why?
Cost-Benefit Analysis
2
2022
122
0.210
Why?
Cardiotoxicity
2
2020
6
0.210
Why?
Age Distribution
2
2020
84
0.210
Why?
Insulin-Like Growth Factor I
1
2024
59
0.210
Why?
Pulmonary Veins
1
2023
17
0.210
Why?
Minority Groups
1
2023
78
0.210
Why?
Maternal Mortality
1
2023
7
0.210
Why?
Morbidity
2
2019
49
0.210
Why?
Health Promotion
2
2016
154
0.210
Why?
Death
1
2023
44
0.200
Why?
Out-of-Hospital Cardiac Arrest
1
2022
7
0.200
Why?
Philippines
1
2022
4
0.200
Why?
Pregnant Women
1
2022
14
0.200
Why?
Pregnancy Outcome
1
2022
17
0.200
Why?
Adolescent
2
2020
2172
0.200
Why?
Cesarean Section
1
2022
29
0.200
Why?
Vitamin K
1
2022
5
0.200
Why?
Attitude
1
2022
32
0.200
Why?
Polypharmacy
1
2022
7
0.200
Why?
Sotalol
1
2021
1
0.200
Why?
Prospective Studies
3
2023
1665
0.190
Why?
Venous Thromboembolism
1
2022
34
0.190
Why?
Pandemics
2
2023
240
0.190
Why?
Coronary Circulation
2
2020
24
0.190
Why?
Cardiac Electrophysiology
1
2021
2
0.190
Why?
Troponin
1
2021
5
0.190
Why?
Sexism
1
2021
6
0.190
Why?
Death, Sudden, Cardiac
1
2021
10
0.190
Why?
Shock, Cardiogenic
1
2021
7
0.190
Why?
Telemedicine
1
2023
104
0.190
Why?
Diagnostic Techniques, Cardiovascular
1
2021
3
0.190
Why?
Water-Electrolyte Imbalance
1
2021
2
0.190
Why?
Hormones
1
2021
11
0.190
Why?
Alcohol Drinking
1
2022
75
0.180
Why?
Overweight
1
2022
72
0.180
Why?
National Institutes of Health (U.S.)
1
2021
22
0.180
Why?
Sleep Apnea, Obstructive
1
2022
60
0.180
Why?
Women's Rights
1
2021
2
0.180
Why?
Signal Processing, Computer-Assisted
2
1998
32
0.180
Why?
Angioplasty
1
2020
6
0.180
Why?
Peripheral Arterial Disease
1
2020
3
0.180
Why?
Weight Loss
1
2022
121
0.180
Why?
Physician-Patient Relations
1
2021
33
0.180
Why?
Career Choice
1
2021
29
0.180
Why?
Heart Valve Diseases
1
2020
15
0.180
Why?
Health Expenditures
1
2020
17
0.180
Why?
Hyperlipidemias
1
2020
18
0.180
Why?
Disease Outbreaks
1
2021
79
0.180
Why?
Periodicals as Topic
1
2021
37
0.180
Why?
Postoperative Hemorrhage
1
2020
24
0.180
Why?
Endovascular Procedures
1
2020
31
0.170
Why?
Accidental Falls
1
2022
111
0.170
Why?
Myocardial Revascularization
1
2020
16
0.170
Why?
Postnatal Care
1
2020
6
0.170
Why?
Delivery, Obstetric
1
2020
10
0.170
Why?
Infant, Newborn
1
2022
563
0.170
Why?
Heart Valve Prosthesis Implantation
1
2020
18
0.170
Why?
Clinical Trials as Topic
1
2021
211
0.170
Why?
Radiation-Protective Agents
1
2020
2
0.170
Why?
Colchicine
1
2020
8
0.170
Why?
Protective Factors
1
2020
22
0.170
Why?
Odds Ratio
2
2020
247
0.170
Why?
Social Class
1
2020
59
0.170
Why?
Prostatic Neoplasms
1
2021
91
0.170
Why?
Income
1
2020
73
0.170
Why?
Thrombolytic Therapy
1
2020
47
0.170
Why?
After-Hours Care
1
2019
1
0.170
Why?
Global Health
1
2019
37
0.170
Why?
Radiation Injuries
1
2020
27
0.170
Why?
Cardiac Resynchronization Therapy
1
2019
7
0.160
Why?
Health Behavior
1
2020
160
0.160
Why?
Up-Regulation
2
2021
166
0.160
Why?
Surveys and Questionnaires
3
2022
1034
0.160
Why?
Multimodal Imaging
1
2019
20
0.160
Why?
Heart
1
2019
54
0.160
Why?
Treatment Refusal
1
2018
10
0.150
Why?
Heart Transplantation
1
1998
25
0.150
Why?
Reproducibility of Results
3
2017
683
0.150
Why?
Asia, Western
1
2018
2
0.150
Why?
Indian Ocean Islands
1
2018
2
0.150
Why?
Graft Rejection
1
1998
62
0.150
Why?
Procainamide
1
1998
1
0.150
Why?
Walking
1
2020
249
0.150
Why?
Atrial Flutter
1
1998
5
0.150
Why?
Intensive Care Units
1
2021
298
0.150
Why?
Tachycardia
2
2021
9
0.150
Why?
Sulfonamides
1
1998
40
0.150
Why?
Memory Disorders
1
2019
155
0.150
Why?
Diagnosis, Differential
1
2019
343
0.150
Why?
Inpatients
1
2019
142
0.140
Why?
Coronary Disease
2
2020
64
0.140
Why?
Echocardiography
4
2023
92
0.140
Why?
Lupus Erythematosus, Systemic
1
2020
173
0.140
Why?
Patient Discharge
1
2018
152
0.140
Why?
Evidence-Based Medicine
1
2018
169
0.140
Why?
Neoplasms
1
2020
224
0.140
Why?
Diet Surveys
1
2017
22
0.140
Why?
Rivaroxaban
1
2016
4
0.140
Why?
Patient Selection
2
2020
184
0.140
Why?
Dabigatran
1
2016
4
0.140
Why?
Pyridones
1
2016
9
0.140
Why?
Thiazoles
1
2016
18
0.140
Why?
Nutrition Assessment
1
2017
44
0.140
Why?
Evidence-Based Practice
1
2017
79
0.140
Why?
Pyridines
1
2016
33
0.130
Why?
Dementia
1
2022
521
0.130
Why?
Pyrazoles
1
2016
35
0.130
Why?
Sensitivity and Specificity
2
2015
473
0.130
Why?
Coronary Vessels
2
2021
32
0.130
Why?
Georgia
1
2016
10
0.130
Why?
Platelet Aggregation Inhibitors
1
2016
45
0.130
Why?
Cholesterol, LDL
1
2016
29
0.130
Why?
Health Surveys
1
2016
81
0.130
Why?
Self Efficacy
1
2016
56
0.130
Why?
Chicago
2
2016
857
0.130
Why?
Equipment Design
2
2015
134
0.120
Why?
Miniaturization
1
2015
2
0.120
Why?
Diet, Mediterranean
1
2017
95
0.120
Why?
Heart Rate
2
2009
105
0.120
Why?
Preventive Health Services
1
2015
15
0.120
Why?
Equipment Failure Analysis
1
2015
106
0.120
Why?
Smoking
2
2018
164
0.110
Why?
Cardiac Pacing, Artificial
2
1992
17
0.110
Why?
Needs Assessment
1
2013
35
0.110
Why?
Drug Monitoring
1
2012
15
0.100
Why?
Heart Conduction System
1
1992
10
0.100
Why?
Data Collection
1
2012
88
0.100
Why?
Vascular Endothelial Growth Factor A
2
2024
59
0.100
Why?
Activities of Daily Living
1
2016
571
0.100
Why?
Registries
3
2022
170
0.100
Why?
Motor Activity
1
2013
311
0.090
Why?
Blood Pressure
2
2023
197
0.090
Why?
Coronary Artery Bypass
2
2020
25
0.080
Why?
Survival Rate
2
2019
315
0.080
Why?
Severity of Illness Index
2
2021
853
0.070
Why?
Databases, Factual
2
2019
315
0.070
Why?
Time Factors
3
2021
1347
0.070
Why?
Azetidines
1
2006
2
0.070
Why?
Benzylamines
1
2006
10
0.070
Why?
Body Mass Index
2
2020
432
0.060
Why?
Endpoint Determination
1
2004
13
0.060
Why?
Postoperative Complications
2
2020
825
0.060
Why?
Blood Pressure Monitoring, Ambulatory
1
2023
3
0.050
Why?
Brain-Derived Neurotrophic Factor
1
2024
48
0.050
Why?
Pharmacists
1
2023
16
0.050
Why?
Follow-Up Studies
2
2019
1722
0.050
Why?
Urokinase-Type Plasminogen Activator
1
2022
2
0.050
Why?
Receptors, Urokinase Plasminogen Activator
1
2022
20
0.050
Why?
Double-Blind Method
2
2006
411
0.050
Why?
Flecainide
1
2021
1
0.050
Why?
Genetic Testing
1
2022
57
0.050
Why?
Delivery of Health Care
1
2023
147
0.050
Why?
Microcirculation
1
2021
28
0.050
Why?
Ischemia
1
2021
20
0.050
Why?
Diuretics
1
2021
6
0.050
Why?
Pregnancy, High-Risk
1
2021
2
0.050
Why?
Peripartum Period
1
2021
3
0.050
Why?
Chlorides
1
2021
20
0.050
Why?
Recurrence
2
2006
288
0.050
Why?
Sodium
1
2021
50
0.040
Why?
Health Services Research
1
2021
40
0.040
Why?
Patient Preference
1
2021
29
0.040
Why?
Lactation
1
2021
51
0.040
Why?
Hypercholesterolemia
1
2020
26
0.040
Why?
Education, Medical
1
2021
42
0.040
Why?
Fetal Growth Retardation
1
2020
3
0.040
Why?
Polycystic Ovary Syndrome
1
2020
2
0.040
Why?
Menopause, Premature
1
2020
5
0.040
Why?
Abortion, Spontaneous
1
2020
5
0.040
Why?
Case-Control Studies
2
2000
567
0.040
Why?
Sleep Apnea, Central
1
2000
29
0.040
Why?
Health Care Costs
1
2020
72
0.040
Why?
Clinical Decision-Making
1
2020
40
0.040
Why?
Attitude to Health
1
2020
93
0.040
Why?
Radiotherapy
1
2020
31
0.040
Why?
Neuropsychological Tests
1
2024
1192
0.040
Why?
Costs and Cost Analysis
1
2019
28
0.040
Why?
Curriculum
1
2021
160
0.040
Why?
Autoimmune Diseases
1
2020
48
0.040
Why?
Disease Management
1
2020
104
0.040
Why?
Multivariate Analysis
1
2020
296
0.040
Why?
Thrombectomy
1
2019
28
0.040
Why?
Cause of Death
1
2019
55
0.040
Why?
Psychology
1
2018
21
0.040
Why?
Health Services Needs and Demand
1
2018
55
0.040
Why?
Heredity
1
2018
7
0.040
Why?
Cancer Survivors
1
2018
11
0.040
Why?
Diabetes Mellitus, Type 2
1
2020
183
0.040
Why?
Quality Improvement
1
2018
140
0.030
Why?
Diet, Western
1
2017
9
0.030
Why?
Breast Feeding
1
2018
137
0.030
Why?
Drug Therapy, Combination
1
2016
169
0.030
Why?
Genetic Predisposition to Disease
1
2018
380
0.030
Why?
Waist Circumference
1
2015
34
0.030
Why?
Risk
1
2016
197
0.030
Why?
Decision Making
1
2018
211
0.030
Why?
Body Composition
1
2016
64
0.030
Why?
Body Weight
1
2016
137
0.030
Why?
Patient Compliance
1
2016
148
0.030
Why?
Wolff-Parkinson-White Syndrome
1
1993
1
0.030
Why?
Dextroamphetamine
1
1993
2
0.030
Why?
Syncope
1
1993
3
0.030
Why?
Hypotension, Orthostatic
1
1993
11
0.030
Why?
Social Networking
1
2013
10
0.030
Why?
Efficiency
1
2013
19
0.030
Why?
Albuterol
1
1993
15
0.030
Why?
Bradycardia
1
1993
22
0.030
Why?
Interviews as Topic
1
2013
132
0.030
Why?
Program Evaluation
1
2013
123
0.030
Why?
Tachycardia, Ventricular
1
1992
20
0.030
Why?
Cardiac Catheterization
1
1992
60
0.020
Why?
Animals
1
2020
3551
0.020
Why?
Asthma
1
1993
108
0.020
Why?
Chemical and Drug Induced Liver Injury
1
2006
5
0.020
Why?
Estrogen Replacement Therapy
1
2006
18
0.020
Why?
Thromboembolism
1
2006
15
0.020
Why?
Chi-Square Distribution
1
2006
131
0.020
Why?
Proportional Hazards Models
1
2006
321
0.010
Why?
Combined Modality Therapy
1
2004
294
0.010
Why?
Electrocardiography, Ambulatory
1
2000
11
0.010
Why?
Tracheostomy
1
2000
26
0.010
Why?
Bronchoscopy
1
2000
34
0.010
Why?
Respiration
1
2000
34
0.010
Why?
Anesthesia
1
2000
30
0.010
Why?
Child
1
2000
1326
0.010
Why?
False Positive Reactions
1
1993
34
0.010
Why?
Contraindications
1
1993
30
0.010
Why?
Action Potentials
1
1993
78
0.010
Why?
Administration, Inhalation
1
1993
31
0.010
Why?
Posture
1
1993
59
0.010
Why?
ROC Curve
1
1992
133
0.010
Why?
Analysis of Variance
1
1992
259
0.010
Why?
Volgman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (370)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_